Advancing the Digital Health Discussion at JPM 2021

In its 39th year, JPMorgan’s annual Healthcare Conference was virtual for the first time in the event’s history. The upside? No travel on a very expensive flight into SFO, to spend thousands on a hotel room I barely spent time in. No waiting for an Uber to take me across town to an event (in the rain and wind so typical of the time of year).

Although the event was going to be virtual, we at BrightInsight wanted to continue advancing the digital health discussion as we have done for the last four years through our in-person events at JPM. So, this year, we collaborated with HealthXL to co-host our Digital Health C-Suite Series™ with luminaries from medtech, biopharma as well as the consumer, automotive and finance industries, to participate in invite-only, intimate Zoom gatherings.

Over the course of four days, several dozen biopharma and medtech executives, investors and industry influencers engaged in lively conversation with our guest speakers, as they shared lessons learned, posed insightful questions and made predictions for the future of digital adoption and transformation for biopharma and medtech.

Here’s a quick recap of our Digital Health C-Suite Series discussions:

Here are some of the key themes that emerged:

1. Co-Creation of Digital is Key: Take Digital Out of the Silo

Across all of the sessions, the speakers and guests agreed that from the C-Suite to R&D and Commercial—all should feel ownership of the success of digital products.

2. Fail Fast and Keep Moving Forward.

3. Take a different approach to digital talent acquisition, cultivation and reward.

4. Show Me the Money.

Biopharma should consider investing in digital products or therapeutics the way they think about investing in traditional biopharma products and drugs.

5. Regulatory cannot be an afterthought.

We wrapped the C-Suite Series on Thursday evening with a virtual wine tasting with our local Sonoma favorite, Scribe Winery, featuring a fireside chat with Mark Bartolini, Former Chairman and CEO, Aetna.

All in all, a fantastic week. Thanks to everyone who joined our sessions and hope to see you all in person someday soon!


Back to Blog